[HTML][HTML] Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases
MER Butchbach - Frontiers in molecular biosciences, 2016 - frontiersin.org
Proximal spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide,
is an early-onset, autosomal recessive neurodegenerative disease characterized by the loss …
is an early-onset, autosomal recessive neurodegenerative disease characterized by the loss …
Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development
MER Butchbach - International Journal of Molecular Sciences, 2021 - mdpi.com
Spinal muscular atrophy (SMA) is a leading genetic cause of infant death worldwide that is
characterized by loss of spinal motor neurons leading to muscle weakness and atrophy …
characterized by loss of spinal motor neurons leading to muscle weakness and atrophy …
[PDF][PDF] Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal …
M Feldkötter, V Schwarzer, R Wirth, TF Wienker… - The American Journal of …, 2002 - cell.com
Spinal muscular atrophy (SMA) is a common autosomal recessive disorder in humans,
caused by homozygous absence of the survival motor neuron gene 1 (SMN1). SMN2, a …
caused by homozygous absence of the survival motor neuron gene 1 (SMN1). SMN2, a …
Survival, motor function, and motor milestones: comparison of AVXS-101 relative to nusinersen for the treatment of infants with spinal muscular atrophy type 1
O Dabbous, B Maru, JP Jansen, M Lorenzi… - Advances in …, 2019 - Springer
Introduction Infants with spinal muscular atrophy (SMA) type 1 typically face a decline in
motor function and a severely shortened life expectancy. Clinical trials for SMA type 1 …
motor function and a severely shortened life expectancy. Clinical trials for SMA type 1 …
[PDF][PDF] Splicing regulation in neurologic disease
DD Licatalosi, RB Darnell - Neuron, 2006 - cell.com
The importance of alternative splicing in the regulation of diverse biological processes is
reflected in the growing list of human diseases associated with known or suspected splicing …
reflected in the growing list of human diseases associated with known or suspected splicing …
RNA-binding proteins in neurodegeneration: mechanisms in aggregate
Neurodegeneration is a leading cause of death in the developed world and a natural, albeit
unfortunate, consequence of longer-lived populations. Despite great demand for therapeutic …
unfortunate, consequence of longer-lived populations. Despite great demand for therapeutic …
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
LA Skordis, MG Dunckley, B Yue… - Proceedings of the …, 2003 - National Acad Sciences
The multiplicity of proteins compared with genes in mammals owes much to alternative
splicing. Splicing signals are so subtle and complex that small perturbations may allow the …
splicing. Splicing signals are so subtle and complex that small perturbations may allow the …
[图书][B] ДНК-диагностика и медико-генетическое консультирование в неврологии
СН Иллариошкин, ИА Иванова-Смоленская… - 2002 - elibrary.ru
Монография посвящена современным возможностям ДНК-диагностики и основанного
на ней медико-генетического консультирования при наследственных заболеваниях …
на ней медико-генетического консультирования при наследственных заболеваниях …
Antisense oligonucleotide-based therapy for neuromuscular disease
Neuromuscular disorders such as Duchenne Muscular Dystrophy and Spinal Muscular
Atrophy are neurodegenerative genetic diseases characterized primarily by muscle …
Atrophy are neurodegenerative genetic diseases characterized primarily by muscle …
A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy
X Wu, SH Wang, J Sun, AR Krainer… - Human molecular …, 2017 - academic.oup.com
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by reduced expression
of survival of motor neuron (SMN), a protein expressed in humans by two paralogous genes …
of survival of motor neuron (SMN), a protein expressed in humans by two paralogous genes …